Imperial Chemical Industries Limited

Zeneca Limited

Ici Pharma

Zeneca Pharma

Jonathan Hutton

David Waterson

The invention concerns quinolinium salt intermediates of the formula I ##STR1## and processes for their manufacture; and their use in the manufacture of aryloxymethyl-substituted 1-alkyl-2-quinolone derivatives which are 5-lipoxygenase inhibitors.

Crystalline 1-alkyl-2-quinolinium salts

A process for the preparation of a 5,7-diaryloxy-2-(2-heteroaryl)-triazolo[1,5-a][1,3,5]triazine, which comprises reacting a N-2-(4,6-diaryloxy)-[1,3,5]triazinyl-N'-(2-heteroarylcarbonyl)hydrazine with a polyphosphoric acid silyl ester. The invention also provides a multistep process for preparing certain triazolotriazines having activity asadenosine antagonists.

Chemical process

Process for the manufacture of crystalline quinolinium salts and their

An improved process for the preparation of p-hydroxybenzyl cyanide by the reaction of p-hydroxybenzyl alcohol with an alkali metal cyanide, by carrying out the process in the presence of an alkyl formate, especially n-propyl formate. The cyanide product is a valuable intermediate for the preparation of the .beta.-adrenergic blocking agent atenolol.

Growing community of inventors

Adlington, United Kingdom

Jonathan Hutton